Glaxo, SK bioscience start final trial of Covid jab

The vaccine is facing a Phase 3 clinical trial to assess its "safety and immunogenicity" when compared with AstraZeneca's Covid vaccine, the two companies said in a joint statement.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3jsBpUA
via IFTTT